In December 2018, the Medicines and Healthcare Products Regu…
In December 2018, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced that all oral lidocaine-containing products for teething in children would be reclassified from General Sale medicines to Pharmacy medicines. a) What change must manufacturers make to the packaging of this product to comply with labelling legislation? (1 mark) b) What change should occur in pharmacies regarding where these products are displayed? Is this change a legal requirement or a good practice requirement? (2 marks) c) Describe how the legal sale of these products from a pharmacy is affected by this change in classification. Include in your answer a definition of any key terms. (2 marks)